Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (54997)	7/17/2000 11:40:04 PM
From: StocksDATsoar	Respond to of 150070

ragingbull.altavista.com QCL Group tried to aquire DNAprint... Interesting reading on our companies past. WATKINSVILLE, Ga.--Jan. 10, 2000--QCL Group, Inc. has signed a letter of intent to acquire Gaff Biologic and www.dnaprint.com. QCL Group, Inc. is a holding company based near Atlanta, Ga. "Gaff Biologic will be a strong addition to our growing portfolio of wholly owned subsidiaries. It offers unique products and services in a growing industry and is poised to expand rapidly. With their patent application we think that this is a great industry opportunity for our company" said QCLG's chairman Pete Iodice. GAFF biologic is a development stage biotechnology company focused on genetic discovery and development. Until now, the company has been researching and developing new genetic products and has financially supported this endeavor by performing scientific research support services for the academic and industrial community. The company has strategic alliances with independent scientists at the University of Hawaii, and in Florida and is negotiating product license agreements with several major biotech companies. To date Gaff those profitable has not generated significant revenue. GAFF biologic owns DNAPrint.com, a DNA laboratory that provides personal genetic sequence profiles for internet-based application to genealogy. The company enables customers to construct/test genetically accurate family trees and determine gene and trait inheritance patterns over several generations. DNA is collected by rubbing a soft swab against the inner cheek lining and depositing on a special DNA card. Collection kits are $24.95 per person. The DNA analysis (formally called STR DNA typing analysis) is performed on state-of-the-art capillary electrophoresis equipment and costs $120 per person. The company produces DNA testing for parents and their newborns to eliminate the possibility of baby mix-ups, and performs analyses for forensic organizations and health care facilities around the country. DNAPrint.com owns a variety of proprietary systems, including patent pending DNA analysis reagents (TruSeq[TM], patent pending), tools, software applications (FEM[TM] software system) and laboratory information management systems that, for the first time ever, enable high-throughput genetic analysis on an economical scale. Gaff believes that these products will allow it to become a force in the market for biological/medical related software tools and genetic identification services. The market is presently estimated to generate over $25 billion annually, and if current technology developments and trends continue, could exceed $160 billion by the year 2005. Genealogy is also a multi billion dollar industry- DNAPrint.com is the first online DNA genealogy company in the world. The company is located in Sarasota, Florida and was founded by Tony Frudakis, Ph.D, graduate of Molecular and Cell Biology from the University of California at Berkeley. Dr. Frudakis is an accomplished molecular biologist with over 13 years of experience. He is an inventor of 15 genetically relevant patents, covering numerous genes and DNA related product. Dr. Frudakis said, "We are pleased to be talking with QCL group. Becoming part of a public company will allow us to more efficiently execute our business plan, and associating with this particular group would provide our company with impressive Internet, software design, and hardware resources." QCLG has been focusing on finding Internet related e-commerce companies to acquire or develop. QCL Group, Inc. is also developing Quickvend (www.quickvend.com), and other software applications.

To: Jim Bishop who wrote (54997)	7/17/2000 11:42:06 PM
From: StocksDATsoar	Respond to of 150070

ragingbull.altavista.com Their getting ready!! DNAPrint Genomics Postdoctoral In Bioinformatics or Computer Science Tony Frudakis, Ph.D. Chief Scientific Officer DNAPrint genomics 1748 Independence Blvd. Suite D1 Sarasota, FL 34234 (941) 351-4543 www.dnaprint.com dnaprint@gte.net DNAPrint genomics is a young bioinformatics company based in South Florida. We specialize in the complex analysis of single nucleotide polymorphism(SNP) databases for the discovery of novel disease related genes and pathways. We are building a multi-dimensional and artificially intelligent software platform to identify commonality and pattern between individual person-SNP matricies for a better dissection of complex (involving more than one gene) genetic phenotypes. Our target areas are cancer and drug response. We have the following position available at this time: REQUIREMENTS: Programming ability in some or all of the following Perl, C/C++, SQL, MATLAB Ability to manage an Oracle or Database Professional of Personal experience with fuzzy Neural Networks DESIRED: Basic Knowledge of Biology and Genetics Entrepenurial and Creative Spirit SALARY: $40,000-$50,000 plus Stock Option Incentives TERM: One year, with extensions based on performance DESCRIPTION: You will work closely with our mathemetician/Director of Informatics, and possibly another programmer, to implement established and novel mathematical concepts into biologically relevant code for the detection of patterns between SNP matricies (populations, individuals etc.). The software that will result will be used around the world for disease research and pharmacogenetics screening. For more information, please visit our website www.dnaprint.com. CONTACT: Please send your resume to Tony Frudakis, Ph.D, dnaprint@gte.net,(941) 351-4543 or Kim, mhgim@hotmail.com

To: Jim Bishop who wrote (54997)	7/17/2000 11:43:45 PM
From: StocksDATsoar	Respond to of 150070

ragingbull.altavista.com this will be huge!!! DNA Detectives This summer scientists are poised to reach a historic milestone – the mapping of the human genome. As researchers try to decipher this raw genetic data and find treatments for many intractable diseases, they are turning to dot-coms for help. By Todd Woody Drive through Oakland, Calif., on Highway 580 and you'll see a sign of the times. Amid a jumble of advertisements for dot-com this and dot-com that stands a bright-blue billboard emblazoned with a double helix: The symbol for DNA, the building block of life. The sign reads, "General Admission to the Human Genome. DoubleTwist.com: Portal to the Code." Nearby, at DoubleTwist's headquarters, there are no white-coated technicians, no laboratories. The DNA is digital, residing on dozens of Sun Microsystems (SUNW) computers. The microwave-size black boxes are everywhere – in hallways, next to water coolers, beside a Foosball table. The computers store millions of genetic sequences derived from the massive international effort, nearly complete, to map the human genome. Using the raw data stored at DoubleTwist and elsewhere, scientists from the public and private sectors will spend decades in a worldwide effort to try to identify specific genes and their functions in the hope of treating and curing a range of medical disorders. Internet-based companies like DoubleTwist have emerged to give those scientists access to gene databases and the tools to conduct their research online with colleagues around the world in a field of study called genomics. These online genomics companies are not only changing the way scientists work, they're also using the Internet to offer genetic services directly to people. Early next year a genomics company called Orchid BioSciences intends to offer a service that will let you scrape off cells from the inside of your cheek and mail them to New Jersey for DNA analysis. You'll then go online to see whether your genetic profile predisposes you to adverse drug reactions. And this summer, a Jim Clark-backed company, Kiva Genetics, plans to begin recruiting on WebMD.com for volunteers willing to donate their DNA for genetic studies. That's just the beginning. "We're going to provide secure access to individuals' genetic profiles," Celera Genomics President J. Craig Venter recently told investment bankers. It's just a matter of time, predict some genomics executives, before you'll go online to find out whether your genetic profile destines you to develop Alzheimer's or other ailments. Says Jonathan Rothberg, CEO of online genomics company CuraGen (CRGN) : "There's no aspect of your life that isn't going to be affected by this, from conception to death." But as life itself becomes dot-commed, economic and ethical dilemmas loom. Until these DNA dot-coms prove their worth by helping discover profitable new medicines, Wall Street's current craze for genomics remains speculative. What's more, the prospect of one's DNA being transmitted and shared over the Web raises thorny issues of privacy, confidentiality and the ethics of genetic testing to new levels. Even some genetic scientists worry that science is outstripping public sentiment. Warns Stanford University biochemist Douglas Brutlag, who serves as DoubleTwist's chief scientific officer: "There are important social and ethical issues at play here, and those issues have been underestimated by genomicists ragingbull.altavista.com ragingbull.altavista.com